267 related articles for article (PubMed ID: 12924019)
1. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
[TBL] [Abstract][Full Text] [Related]
2. [Effect of streptokinase on the interaction of alpha-2-antiplasmin with different sites of plasmin molecule].
Iusova EI; Grinenko TV; Volkov GL
Ukr Biokhim Zh (1999); 2004; 76(2):98-106. PubMed ID: 15915719
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
4. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
5. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
Christensen U; Bangert K; Thorsen S
FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
[TBL] [Abstract][Full Text] [Related]
6. Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.
Christensen S; Sottrup-Jensen L; Christensen U
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):97-102. PubMed ID: 7529997
[TBL] [Abstract][Full Text] [Related]
7. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
Ries M; Zenker M
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
[TBL] [Abstract][Full Text] [Related]
8. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
[TBL] [Abstract][Full Text] [Related]
9. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
Zhabin SG; Zorin NA; Musatov MI
Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
[TBL] [Abstract][Full Text] [Related]
10. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
Lin LF; Houng A; Reed GL
Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nonproteolytic active site formation in plasminogen.
Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
[TBL] [Abstract][Full Text] [Related]
13. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
Silence K; Collen D; Lijnen HR
J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
[TBL] [Abstract][Full Text] [Related]
14. Binding site of alpha 2-plasmin inhibitor to plasminogen.
Sugiyama N; Sasaki T; Iwamoto M; Abiko Y
Biochim Biophys Acta; 1988 Jan; 952(1):1-7. PubMed ID: 3334852
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
16. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
Wiman B; Lijnen HR; Collen D
Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
[TBL] [Abstract][Full Text] [Related]
17. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
Sokolovskaya LI; Slominskii AY; Volkov GL
Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
[TBL] [Abstract][Full Text] [Related]
18. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
[TBL] [Abstract][Full Text] [Related]
19. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the inhibition of plasmin in acidified human plasma.
Lijnen HR; Maes M; Castel M; Samama M; Collen D
Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
